Xianqiang Xie
Overview
Explore the profile of Xianqiang Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
5
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Gu H, Liu X, Wang H, Zhang N, Liao J, et al.
Adv Mater
. 2024 Oct;
36(48):e2410408.
PMID: 39394801
2D Ruddlesden-Popper perovskites (RPPs) have attracted extensive attention in recent years due to their excellent environmental stability. However, the power conversion efficiency (PCE) of RPP solar cells is much lower...
2.
Cui X, Xie G, Liu Y, Xie X, Zhang H, Li H, et al.
Adv Mater
. 2024 Sep;
36(45):e2408646.
PMID: 39292203
The compatibility of perovskite and organic photovoltaic materials in solution processing provides a significant advantage in the fabrication of high-efficiency perovskite/organic tandem solar cells. However, additional recombination losses can occur...
3.
Liao H, Zeng T, Xie X, Li J, Li D, Yan K, et al.
J Gastrointest Oncol
. 2024 Sep;
15(4):1568-1579.
PMID: 39279951
Background: Currently, the benefits of the administration of adjuvant chemotherapy (AT) in pathological low-risk rectal mucinous adenocarcinoma (RM) with T1-3N0M0 are unclear. The objective of this study is to retrospectively...
4.
Liao H, Zeng T, Xie X, Li J, Li D, KejinYan , et al.
Int J Colorectal Dis
. 2023 May;
38(1):134.
PMID: 37199862
Purpose: Adjuvant chemotherapy is controversial in rectal cancer, especially after neoadjuvant chemoradiotherapy (NCRT). This retrospective study aims at evaluating adjuvant chemotherapy's long-term survival benefits in stage II and stage III...